Clinical Trials
2 trialsNCT04589754 2024-01-02
Adriamycin and Ifosfamide Combined With Sintilimab
Sun Yat-sen University
Phase 2 Recruiting
NCT04356872 2020-07-14
The Combination of Sintilimab and AI (Doxorubicin, ADM/Ifosfamide, IFO) for the First Line Treatment of Select Type of Metastatic/Unresectable Soft Tissue Sarcoma
Fudan University
Phase 2 Unknown